With The Demand For Dietary Supplements And Nutraceutical Type Products Going Up And FDA Stepping In To Regulate The Industry, ChromaDex Is In The Right Place By Establishing Reference Standards And Analytical Test Methods To Accurately Identify And Test For Quality

ChromaDex Corp. (CDXC-OTC: BB)

wpe11.jpg (7184 bytes)

“Long-term, the picture is bright for us, increased regulations are good for our business, and there is definitely not going to be a decrease of regulation over the next three to five years. The FDA’s new regulations on Good Manufacturing Practices are going to be very positive for us in the long-run. The increased demand for natural products is also something that, you see in the press almost every day, everybody wants organic, clean, green sustainable products and that is really, where we operate. As the need and demand for these types of products continues to grow it is really going to keep driving the market for us long-term.” - Frank L. Jaksch Jr. (CDXC) (Interview published August 22, 2008)

The Most Powerful Name In Corporate News and Information.

CURRENT ISSUE  |  COVER ARCHIVES  |   INDEX   |  CONTACT  |  FINANCIALS  |  MARKETING SERVICES   |   HOME PAGE


CEOCFO
-Members Login

Become A Member!



 


Become a member and access our interview with:

Frank L. Jaksch Jr., CEO (CDXC)

wpe8CC.jpg (12410 bytes)


    

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.